Adamax vs Semax: ACTH-Fragment Peptide Research
Adamax is a Semax analog modified with an adamantane group. Research indicates this change may increase neurotropic activity by up to 100x over Semax.
Tag: brain peptides
Spadin Research: TREK-1 Channel and Neuropeptide Studies
Spadin research shows rapid antidepressant effects in animal models within 4 days via TREK-1 channel blockade. Covers neurogenic and cognitive studies.
Peptides in Neurogenesis Research: Current Studies
Peptide neurogenesis research studies how Semax, PE-22-28, and NAD+ affect BDNF expression and hippocampal neuron formation in preclinical lab models.
How Peptides Cross the Blood-Brain Barrier
Blood-brain barrier peptide research maps how peptides enter the CNS. Studies on Semax and Selank show these cross via active transport in lab models.
CNS Bioregulators: Neural Peptide Research Studies
CNS bioregulator research: Cortagen, Semax, Selank, and PE-22-28 studied in neural and brain cell models. Cell and animal model data only.
B12 Research Peptide: Methylcobalamin Nerve Cell Studies
Review B12 research: methylcobalamin in SH-SY5Y nerve cells and rat DRG neurons, homocysteine ELISA, MMA assay, and cobalamin form comparison.
Adamax Research: Vasopressin Analog and Brain Cell Studies
Explore Adamax research: vasopressin B4 analog cell studies, GABA-B and NMDA receptor assays, HPLC methods, and LTP data in rat hippocampal models.
Neuroprotective Peptide Research: Semax, Selank, PE-22-28
Neuroprotective peptide research on Semax, Selank, and PE-22-28: BDNF, TrkB, GABA-A, and CREB biomarker data from neuronal cell models.
PE-22-28 Research: BDNF Mimetic and Neuroplasticity Studies
PE-22-28 as a BDNF mimetic peptide. Cell model data on TrkB receptor binding, CREB signaling, and neuroplasticity studies in published lab models.
Dermorphin Research: Opioid Peptide and Receptor Studies
Dermorphin research covers a natural opioid peptide from frog skin with high mu-opioid receptor strength, studied in binding assays and animal models.